• Featured Product
  • KD/KO Validated

STARD13 Polyclonal antibody

STARD13 Polyclonal Antibody for WB, IF/ICC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human and More (2)

Applications

WB, IHC, IF/ICC, ELISA

Conjugate

Unconjugated

Cat no : 21325-1-AP

Synonyms

Rho GTPase activating protein, GT650, DLC-2, DLC2, DLC 2



Tested Applications

Positive WB detected inMCF-7 cells, HeLa cells
Positive IF/ICC detected inMCF-7 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

21325-1-AP targets STARD13 in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman, mouse, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen STARD13 fusion protein Ag15012
Full Name StAR-related lipid transfer (START) domain containing 13
Calculated Molecular Weight 1113 aa, 125 kDa
Observed Molecular Weight 125 kDa
GenBank Accession NumberBC046563
Gene Symbol STARD13
Gene ID (NCBI) 90627
RRIDAB_2878840
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
WB protocol for STARD13 antibody 21325-1-APDownload protocol
IF protocol for STARD13 antibody 21325-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanIHC,WB

Endocrine

Loss of STARD13 contributes to aggressive phenotype transformation and poor prognosis in papillary thyroid carcinoma

Authors - Chuimian Zeng
  • KD Validated
humanWB

Life Sci

Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis.

Authors - Mengwei Wu
ratWB

Environ Toxicol

MiR-125b enhances doxorubicin-induced cardiotoxicity by suppressing the nucleus-cytoplasmic translocation of YAP via targeting STARD13.

Authors - Xiaoping Jin
human,mouseWB,IHC

Biol Proced Online

Circ_0003570 Suppresses the progression of hepatocellular carcinoma through miR-182-5p/STARD13 regulatory axis

Authors - Xu Zhang